2023-10-16 08:30:08 ET
- PCTEL ( NASDAQ: PCTI ) +48% .
- Essa Pharma ( EPIX ) +32% .
- Almacenes Exito ( EXTO ) +32% .
- Ambrx Biopharma ( AMAM ) +32% Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress.
- E2open Parent Holdings ( ETWO ) +22% .
- Bitdeer Technologies Holding ( BTDR ) +16% .
- Mereo Biopharma Group ( MREO ) +14% Announces Program and Pipeline Updates at Analyst Day Including Interim Data from Ongoing Studies in Osteogenesis Imperfecta (OI), Angelman Syndrome (AS) and Wilson Disease.
- Tantech Holdings ( TANH ) +13% .
- Tempest Therapeutics ( TPST ) +13% .
- Ensysce Biosciences ( ENSC ) +12% .
- Neuraxis ( NRXS ) +11% .
- Intra-Cellular Therapies ( ITCI ) +10% .
- MoonLake Immunotherapeutics ( MLTX ) +10% stock rises after skin disorder drug shows promise in phase 2 trial.
- China SXT Pharmaceuticals ( SXTC ) +9% .
- Immutep Limited ( IMMP ) +9% Announces Publication of Abstracts at ESMO Congress 2023.
- Xeris Biopharma Holdings ( XERS ) +8% Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023.
- Bakkt Holdings ( BKKT ) +7% .
- Hut 8 Mining ( HUT ) +8% .
- FingerMotion ( FNGR ) +7% .
- Faraday Future Intelligent Electric ( FFIE ) +7% Future Is Taking to Protect Stockholder Interests and a Review of 30 Company Achievements Since the End of 2022.
- Lululemon Athletica ( LULU ) +6% .
- Cleanspark ( CLSK ) +6% .
- Lexicon Pharmaceuticals ( LXRX ) +6% .
For further details see:
LULU, CLSK and HUT are among pre market gainers